Cirdan: Funding, Investors & Team (Sep 2026)
Cirdan designs, manufactures and supplies innovative software and imaging solutions for the acceleration and enhancement of diagnosis. Our systems are optimised for pathology and clinical laboratory usage. Cirdan’s primary product is its world-class Laboratory Information System, ULTRA. ULTRA has been designed to streamline laboratory operations and is currently installed in more than 72 laboratories across 6 continents. Another core product is PathLite Compact, a purpose-built system designed specifically for gross imaging within clinical laboratories. The company was founded in 2010 and is headquartered in Lisburn, Northern Ireland and has additional offices in Canada and Australia. Cirdan is also responsible for organising Pathology Horizons, an annual and open CPD conference on the future of pathology. For more information visit - www.pathologyhorizons.com
Cirdan has raised $18.0M across 3 funding rounds on record, the most recent an undisclosed round of $5.4M announced in Apr 2026.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Cirdan Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Cirdan Funding Rounds
Cirdan raised $2.8M in an undisclosed round announced in Oct 2023.
1 years later, an undisclosed round of $9.8M was announced in Oct 2024.
1.5 years later, an undisclosed round of $5.4M was announced in Apr 2026.
Cirdan Founders and Leadership Team
Contact details for the Cirdan team: 1 of 3 have an email address on file.
Start 14-day free trial →Cirdan Funding Compared to Other Health Care Startups
Cirdan's latest round of $5.4M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Cirdan in Health Care and Lisburn
Companies Similar to Cirdan
Renata Medical develops purposeful medical devices for unmet pediatric needs.
Leo Cancer Care provides a streamlined and effective treatment method that empowers patients and instills…
Neubond develops wearable devices for stroke mobility rehabilitation. These devices provide autonomous…
Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.
Nebu-Flow is a manufacturer of the next generation of inhaled drugs for patients with respiratory disorders.…
iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial…
Innovative medical gadgets are created by Creo Medical Limited, situated in Chepstow, South Wales. With a…
TympaHealth has developed the world's first ear and hearing health assessment system. The Tympa system…
NEX Health Intelligence (NEX) is a health-tech business that develops AI-powered software for hospitals to…
Infex Therapeutics acquire, develop and license drugs to treat pandemic infections.
Asterix Health is the workforce solution for modern healthcare.
Gloucester Rugby is a professional English rugby union club that gives up to date with all the information…
Cirdan Funding FAQs
What does Cirdan do?
Cirdan designs, manufactures and supplies innovative software and imaging solutions for the acceleration and enhancement of diagnosis. Our systems are optimised for pathology and clinical laboratory usage. Cirdan’s primary product is its world-class Laboratory Information System, ULTRA. ULTRA has been designed to streamline laboratory operations and is currently installed in more than 72 laboratories across 6 continents. Another core product is PathLite Compact, a purpose-built system designed specifically for gross imaging within clinical laboratories. The company was founded in 2010 and is headquartered in Lisburn, Northern Ireland and has additional offices in Canada and Australia. Cirdan is also responsible for organising Pathology Horizons, an annual and open CPD conference on the future of pathology. For more information visit - www.pathologyhorizons.com
How much funding has Cirdan raised?
Cirdan has raised $18.0M across 3 rounds on record. The most recent is an undisclosed round of $5.4M announced in Apr 2026.
When did Cirdan last raise funding?
Cirdan's most recent funding round on record is an undisclosed round of $5.4M, announced in Apr 2026.
Who founded Cirdan?
FundedIQ lists Cahal Cormican (Founder), Hugh Cormican (Founder), Stephen Dunniece (Founder) at Cirdan.
Where is Cirdan headquartered?
Cirdan is based in Lisburn, United Kingdom.
How many employees does Cirdan have?
Cirdan is in the 51-100 employee band.
How does Cirdan's funding compare to other Health Care startups?
Cirdan's latest round of $5.4M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Cirdan Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cirdan is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.